Mosanna Therapeutics (Series A)
Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- June 10, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $80,000,000
Company Info
- Company Description
- Mosanna Therapeutics is a biotech company rethinking treatment of obstructive sleep apnea (OSA) by developing an easy-to-use nighttime nasal spray that helps restore the body's natural airway control.
- Market
- Obstructive Sleep Apnea Treatment
- Location
- Redwood City, California, USA
- Coinvestors
- Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Broadview Ventures, Norwest, Forty51 Ventures, Supermoon Capital, High-Tech Grunderfonds (HTGF)